Advertisement
Screener

Canopy Growth Corp (CGC) Payment for Contingent Consideration Liability, Investing Activities

2.0 / 5 stars · 16/40 Roast Me

Canopy Growth Corp Payment for Contingent Consideration Liability, Investing Activities

Canopy Growth Corp (CGC) reported Payment for Contingent Consideration Liability, Investing Activities of CAD 8.37 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-06.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities · last filed 2021-08-06

  • Canopy Growth Corp payment for contingent consideration liability, investing activities for the quarter ending 2021-06-30 was 8.37M CAD, a 85.48% increase year-over-year.
  • Canopy Growth Corp payment for contingent consideration liability, investing activities for the quarter ending 2021-03-31 was 1.75M CAD.
  • Canopy Growth Corp payment for contingent consideration liability, investing activities for the quarter ending 2020-12-31 was 8.75M CAD, a 4.29% increase year-over-year.
  • Canopy Growth Corp payment for contingent consideration liability, investing activities for the quarter ending 2020-09-30 was 1.88M CAD.
  • Canopy Growth Corp payment for contingent consideration liability, investing activities for fiscal 2021 was 16.90M CAD, a 30.98% decline from fiscal 2020.
  • Canopy Growth Corp payment for contingent consideration liability, investing activities for fiscal 2020 was 24.48M CAD.
  • Canopy Growth Corp payment for contingent consideration liability, investing activities for fiscal 2019 was 0.00 CAD.
Period endPayment for Contingent Consideration Liability, Investing Activities 3 monthPayment for Contingent Consideration Liability, Investing Activities 6 monthPayment for Contingent Consideration Liability, Investing Activities 9 monthPayment for Contingent Consideration Liability, Investing Activities 12 month
2021-06-308.37M CAD
10-Q · filed 2021-08-06
10.12M CAD
derived: sum of 2 quarters · filed 2021-08-06
18.87M CAD
derived: sum of 3 quarters · filed 2021-08-06
20.75M CAD
derived: sum of 4 quarters · filed 2021-08-06
2021-03-311.75M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-01
10.50M CAD
derived: sum of 2 quarters · filed 2021-06-01
12.39M CAD
derived: sum of 3 quarters · filed 2021-06-01
16.90M CAD
10-K · filed 2021-06-01
2020-12-318.75M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09
10.63M CAD
derived: sum of 2 quarters · filed 2021-02-09
15.14M CAD
10-Q · filed 2021-02-09
9.79M CAD
derived: sum of 4 quarters · filed 2021-08-06
2020-09-301.88M CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-09
6.39M CAD
10-Q · filed 2020-11-09
1.04M CAD
derived: sum of 3 quarters · filed 2021-08-06
9.43M CAD
derived: sum of 4 quarters · filed 2021-08-06
2020-06-304.51M CAD
10-Q · filed 2021-08-06
-844.00K CAD
derived: sum of 2 quarters · filed 2021-08-06
7.55M CAD
derived: sum of 3 quarters · filed 2021-08-06
7.55M CAD
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31-5.36M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-01
3.04M CAD
derived: sum of 2 quarters · filed 2021-06-01
3.04M CAD
derived: sum of 3 quarters · filed 2021-06-01
24.48M CAD
10-K · filed 2021-06-01
2019-12-318.39M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09
8.39M CAD
derived: sum of 2 quarters · filed 2021-02-09
29.84M CAD
10-Q · filed 2021-02-09
2019-09-300.00 CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-09
21.45M CAD
10-Q · filed 2020-11-09
2019-06-3021.45M CAD
10-Q · filed 2020-08-10
2019-03-310.00 CAD
10-K · filed 2021-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87